Trial protocol for SiroSkin: a randomised double-blind placebo-controlled trial of topical sirolimus in chemoprevention of facial squamous cell carcinomas in solid organ transplant recipients.
Saved in:
| Title: | Trial protocol for SiroSkin: a randomised double-blind placebo-controlled trial of topical sirolimus in chemoprevention of facial squamous cell carcinomas in solid organ transplant recipients. |
|---|---|
| Authors: | Dousset L; Frazer Institute, The University of Queensland, Experimental Dermatology Group, Brisbane, Australia. l.dousset@uq.edu.au.; Faculty of Medicine, The University of Queensland, Brisbane, Australia. l.dousset@uq.edu.au., Chambers DC; Faculty of Medicine, The University of Queensland, Brisbane, Australia.; Queensland Lung Transplant Service, The Prince Charles Hospital, Brisbane, Australia., Webster A; NHMRC Clinical Trials Centre, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Department of Renal Medicine and Transplantation, Westmead Hospital, Westmead, NSW, Australia.; Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia., Isbel N; Department of Nephrology and Transplantation Services, Princess Alexandra Hospital, Brisbane, Australia., Campbell S; Department of Nephrology and Transplantation Services, Princess Alexandra Hospital, Brisbane, Australia., Duarte C; Melanoma and Skin Cancer Research Centre, Monash University, Melbourne, VIC, Australia., Collins L; Population Health, QIMR Berghofer Medical Research Institute, Brisbane, Australia., Damian D; Department of Dermatology, The University of Sydney at Royal Prince Alfred Hospital, Camperdown, NSW, Australia.; Melanoma Institute Australia, Sydney, Australia., Tseng A; Department of Nephrology and Transplantation Services, Princess Alexandra Hospital, Brisbane, Australia.; Department of Nephrology and Transplantation Services, Prince Charles Hospital, Brisbane, Australia.; Department of Dermatology, Princess Alexandra Hospital, Brisbane, Australia., Karlsen E; Department of Nephrology and Transplantation Services, Princess Alexandra Hospital, Brisbane, Australia.; Department of Nephrology and Transplantation Services, Prince Charles Hospital, Brisbane, Australia.; Department of Dermatology, Princess Alexandra Hospital, Brisbane, Australia., Ilinsky OV; Department of Nephrology and Transplantation Services, Prince Charles Hospital, Brisbane, Australia.; Department of Dermatology, Princess Alexandra Hospital, Brisbane, Australia., Brown S; Frazer Institute, The University of Queensland, Experimental Dermatology Group, Brisbane, Australia., Schaider H; Department of Nephrology and Transplantation Services, Princess Alexandra Hospital, Brisbane, Australia.; Department of Dermatology, Princess Alexandra Hospital, Brisbane, Australia.; Frazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Australia., Soyer HP; Department of Nephrology and Transplantation Services, Princess Alexandra Hospital, Brisbane, Australia.; Department of Dermatology, Princess Alexandra Hospital, Brisbane, Australia.; Frazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane, Australia., Ospino DA; Melanoma and Skin Cancer Research Centre, Monash University, Melbourne, VIC, Australia., Hogarth S; Melanoma and Skin Cancer Research Centre, Monash University, Melbourne, VIC, Australia., Chong AH; Skin Health Institute, Carlton, VIC, Australia., Mar V; Department of Dermatology, Alfred Hospital, The School of Translational Medicine, Monash University, Melbourne, Australia., McKenzie S; Faculty of Medicine, The University of Queensland, Brisbane, Australia.; Advanced Heart Failure and Cardiac Transplant Unit, The Prince Charles Hospital, Chermside, QLD, Australia., Gin D; Department of Dermatology, Alfred Hospital, The School of Translational Medicine, Monash University, Melbourne, Australia., Fernandez-Penas P; Department of Dermatology, Westmead Hospital, The University of Sydney, Westmead, NSW, Australia., Kern JS; Department of Dermatology, Alfred Hospital, The School of Translational Medicine, Monash University, Melbourne, Australia., Loewe K; Melanoma and Skin Cancer Research Centre, Monash University, Melbourne, VIC, Australia., Roy E; Frazer Institute, The University of Queensland, Experimental Dermatology Group, Brisbane, Australia., Herschtal A; School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia., Khosrotehrani K; Frazer Institute, The University of Queensland, Experimental Dermatology Group, Brisbane, Australia.; Faculty of Medicine, The University of Queensland, Brisbane, Australia.; Department of Nephrology and Transplantation Services, Princess Alexandra Hospital, Brisbane, Australia.; Department of Nephrology and Transplantation Services, Prince Charles Hospital, Brisbane, Australia.; Department of Dermatology, Princess Alexandra Hospital, Brisbane, Australia. |
| Source: | Trials [Trials] 2024 Nov 22; Vol. 25 (1), pp. 789. Date of Electronic Publication: 2024 Nov 22. |
| Publication Type: | Clinical Trial Protocol; Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1745-6215 |
|---|---|
| DOI: | 10.1186/s13063-024-08619-3 |
